Menu Close
The Conversation

Eili Klein

2

Articles

0

Comments
Assistant Professor, Johns Hopkins University

I am an Assistant Professor in the Department of Emergency Medicine at Johns Hopkins University. I am also a fellow at the Center for Disease Dynamics, Economics & Policy in Washington, DC. My research focuses on the role of individuals in the spread of infectious diseases, which sits at the nexus of economics, epidemiology and public policy, and is premised on the idea of incorporating incentives for healthy behavior and their attendant behavioral responses into an epidemiological context to better understand how diseases are transmitted. The vast majority of my research has been on the emergence and spread of antimicrobial drug resistance, focusing in particular on antibiotics and anti-malarial drugs. My research is about evenly split between developing an understanding for the factors that drive resistance through epidemiological studies using large national databases of hospitalization and antibiotic use, and developing an understanding of the underlying ecology and epidemiology (and how this is impacted by human behavior) using models.

Experience

  • 2012–present
    Fellow, Center for Disease Dynamics, Economics & Policy
  • 2012–present
    Assistant Professor, Johns Hopkins University

Education

  • 2012 
    Princeton University, PhD

Publications

  • 2014
    Medical Decision Making, Germs are Germs, and Why Not Take a Risk?: Patients' Expectations for Prescribing Antibiotics in an Inner City Emergency Department
  • 2014
    PLoS ONE, Influenza A H1N1 Pandemic Strain Evolution - Divergence and the Potential for Antigenic Drift Variants
  • 2014
    Antimicrobial Agents and Chemotherapy, Trends in Antibiotic Resistance in Coagulase Negative Staphylococci, United States, 1999-2012
  • 2014
    Journal of Theoretical Biology, The Impact of Heterogeneous Transmission on the Establishment and Spread of Antimalarial Drug Resistance
  • 2014
    Infection and Immunity, Cross-Reactive Immune Responses as Primary Drivers of Malaria Chronicity
  • 2013
    Future Microbiology, The potential impact of age and season on methicillin-resistant Staphylococcus aureus prevalence
  • 2013
    PLoS Computational Biology, Policy Resistance Undermines Superspreader Vaccination Strategies for Influenza
  • 2013
    PLoS Pathogens, Hospital-Community Interactions foster coexistence between methicillin-resistant strains of Staphylococcus aureus
  • 2013
    The American Journal of Epidemiology, The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: A national observational study
  • 2013
    International Journal of Antimicrobial Agents, Antimalarial Drug Resistance: A Review of the Biology and Strategies to Delay Emergence and Spread
  • 2013
    Infection Control & Hospital Epidemiology, Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010
  • 2012
    Proceedings of the Royal Society, Series B: Biological Sciences, Superinfection and the evolution of resistance to antimalarial drugs
  • 2012
    Clinical Infectious Diseases, Seasonality and Temporal Correlation between Community Antibiotic Use and Resistance in the United States
  • 2012
    Malaria Journal, Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana
  • 2010
    The Lancet, Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis
  • 2010
    Journal of Health Economics , Should new antimalarial drugs be subsidized?
  • 2009
    Emerging Infectious Diseases , Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999-2006
  • 2009
    Health Affairs , Global Investments in Tuberculosis Control: Economic Benefits
  • 2008
    Malaria Journal, Clinically Immune Hosts as a Refuge for Drug-Sensitive Malaria Parasites
  • 2008
    Diagnostic Microbiology and Infectious Disease, The Burden of Vancomycin-Resistant Enterococcal Infections in U.S. Hospitals, 2003-2004
  • 2007
    Emerging Infectious Diseases, Hospitalizations and Deaths Caused by Staphylococcus aureus and MRSA, United States, 1999-2004
  • 2007
    Environment and Development Economics, Economic Incentives and Mathematical Models of Disease